Multiple alternative splicing markers for ovarian cancer

Area of Science:

• Molecular Biology
• Genomics
• Cancer Research

Background:

• Gene expression profiling is crucial for discovering cancer markers and drug targets.
• Existing methods have limitations in bridging high-throughput screening and individual gene analysis.
• Alternative splicing events represent a promising area for cancer diagnostics.

Purpose of the Study:

• To introduce a novel, sensitive approach for identifying cancer signatures using alternative splicing.
• To validate the Layered and Integrated System for Splicing Annotation (LISA) for cancer detection.
• To establish a splicing-based signature for diagnosing ovarian cancer.

Main Methods:

• Developed and applied the Layered and Integrated System for Splicing Annotation (LISA).
• Performed high-throughput reverse transcription-PCR validation of alternative splicing events.
• Screened splicing of 600 cancer-associated genes in normal and serous ovarian cancer tissues.

Main Results:

• Identified 48 alternative splicing events significantly associated with serous ovarian tumors out of >4,700 screened.
• The developed ovarian cancer splicing signature accurately distinguished all normal tissues from cancer tissues in a separate cohort.
• Demonstrated the capability of LISA to identify a high volume of cancer-associated splice forms.

Conclusions:

• The Layered and Integrated System for Splicing Annotation (LISA) is an effective tool for identifying cancer-associated alternative splicing events.
• Alternative splicing profiling holds significant potential for the diagnosis of cancer subtypes.
• This approach provides a valuable bridge between large-scale genomic studies and targeted gene investigations.